Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Novo Nordisk AS 2025" company profile has been added to ResearchAndMarkets.com's offering.
The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Novo Nordisk AS (Novo Nordisk), a subsidiary of Novo Holdings AS, is a healthcare company focused on discovering, developing, and delivering biological medicines for therapy areas for diabetes, haemophilia, human growth hormone (HGH) disorders, rare blood and rare endocrine diseases, and obesity.
Its products include pre-filled delivery systems for insulin, glucagon hypokit, cartridge, needles, vials, insulin, estradiol for hormone replacement, recombinant drugs for haemophilia, glucagon, and oral antidiabetic agents.
The company offers its products to patients through brands such as NovoPen, FlexPen, Saxenda, and Ozempic. It markets products through subsidiaries in North America, Europe, Asia, Latin America, Africa, the Middle East, and Australia.
The report provides information and insights into Novo Nordisk's tech activities, including:
- Insights of its digital transformation strategies and innovation programs.
- Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
- Insights on each technology initiative including technology theme, objective, and benefits.
- Details of estimated ICT budgets and major ICT contracts.
Reasons to Buy
- Gain insights into Novo Nordisk's tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnerships, investments, and acquisitions.
Key Topics Covered:
- Novo Nordisk's Overview
- Novo Nordisk's Digital Transformation Strategy
- Novo Nordisk's Accelerators, Incubators, and Innovation Programs
- Novo Nordisk's Technology Focus
- Novo Nordisk's Technology Initiatives
- Novo Nordisk's Investments
- Novo Nordisk's Acquisitions
- Novo Nordisk's Tech Ecosystem
- Novo Nordisk's ICT Budget & Contracts
- Novo Nordisk's Senior Management Team
- Our Thematic Scorecard for the Pharmaceuticals and Healthcare Sector
Companies Featured
- Alibaba Health
- Fangzhou
- NVIDIA
- Eleven Therapeutics
- Valo Health
- Dewpoint Therapeutics
- Diabeloop
- Microsoft
- TetraScience
- Medtronic
- Biocorp
- Abbott
- HighRes Biosolutions
- Form Health
- ORA
- Variant Bio
- NanoVation Therapeutics
- Aspect Biosystems
- Health2Sync
For more information about this company profile visit https://www.researchandmarkets.com/r/g17rcz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
